A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer

HIGHLIGHTS

• who: Jin Wu et al. from the National Cancer Institute at Frederick (NIH), United States Sichuan University, China have published the article: A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer, in the Journal: (JOURNAL)
• what: Our results suggest that a novel signature of 12 genes can be used to predict NAC response and predict prognosis in breast cancer.
• how: The results showed that slowing down the cell cycle and decreasing biological processes and metabolic abnormalities are important mechanisms for the survival of chemo-resistant cells. Considering . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.